Real-World Data Presented by Evoke Pharma and EVERSANA at Digestive Disease Week 2023 Shows Gimoti® Meaningfully Reduces Utilization of Healthcare Resources
09 mai 2023 07h00 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI)...
Evoke Pharma’s Real-World Healthcare Utilization Data Comparing GIMOTI® to Oral Metoclopramide to Be Presented at Digestive Disease Week (DDW) 2023
04 mai 2023 08h30 HE
|
Evoke Pharma, Inc.
Compelling data elevated to distinguished DDW oral plenary session GIMOTI to be showcased in additional activities at conference SOLANA BEACH, Calif., May 04, 2023 (GLOBE NEWSWIRE) --...
Evoke Pharma and EVERSANA Selected to Present Results of Real-World Healthcare Utilization Study Comparing GIMOTI® and Oral Metoclopramide at the Digestive Disease Week Plenary Session
21 févr. 2023 07h00 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
3-D Matrix Medical Technology’s PuraStat® Hemostatic Gel Highlighted by Key Opinion Leaders at Digestive Disease Week®
26 mai 2022 09h00 HE
|
3-D Matrix Medical Technology
Newton, MA, May 26, 2022 (GLOBE NEWSWIRE) -- PuraStat®, a hemostatic agent made by 3-D Matrix Medical Technology, a leading global peptide solutions company, was prominently featured in several key...
Progenity Provides Results from Key Study for Its Targeted Therapeutics Program
26 mai 2021 07h30 HE
|
Progenity, Inc.
SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced results from a further study for the company’s Targeted Therapeutics...
Sean Lavin, MD, Joins Progenity as Vice President, Business Development, Strategy, and Investor Relations
25 mai 2021 07h30 HE
|
Progenity, Inc.
SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the appointment of Sean Lavin, M.D. as Vice President, Business...
Progenity Announces Poster Presentations at Digestive Disease Week 2021
24 mai 2021 07h30 HE
|
Progenity, Inc.
SAN DIEGO, May 24, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the presentation of two posters related to the company’s Targeted...
Metacrine to Present New Preclinical Data on MET642 in Inflammatory Bowel Disease at Digestive Disease Week 2021 Virtual Meeting
19 mai 2021 08h05 HE
|
Metacrine, Inc.
SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal...
Progenity to Present Two Abstracts for Novel Ingestible Drug Delivery Technologies at Digestive Disease Week 2021
26 avr. 2021 07h30 HE
|
Progenity, Inc.
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Flashpoint’s Ronnie Tokazowski Honored by the M3AAWG with JD Falk Award
09 oct. 2018 13h00 HE
|
Flashpoint
NEW YORK, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Flashpoint, the global leader in Business Risk Intelligence (BRI), today announced that Senior Malware Analyst Ronnie Tokazowski has accepted the...